ALEXANDRIA, Va. – A recent Office of Inspector General report on payment for Part B DME infusion drugs is far too narrow to be the basis for new policy, according to the National Home Infusion Association.
WASHINGTON – The Office of Inspector General in a new report reiterates its concerns that, unlike most Part B drugs, Medicare payment amounts for DME infusion drugs are still based on average wholesale prices from 2003.
WASHINGTON – Senior Medicare Patrol projects report $2.5 million in expected recoveries for Medicare in 2015, compared to $660,829 in 2014, a 282% increase, according to a June 3 report from the Office of In
WASHINGTON – The Office of Inspector General (OIG) wants Hoveround to pay back the federal government $27 million for power mobility devices that it says do not meet Medicare reimbursement requirements.
WASHINGTON – Four states could have saved an additional $12 million on certain DME items by using pricing comparable to Round 2 of competitive bidding and the national mail-order programs, according to a recent
WASHINGTON – The Office of Inspector General has certified $133.2 million of actual and projected savings from CMS’s Fraud Prevention System, a return of investment of $2.84 for every dollar spent on the system.